Baseball Great Blames Smokeless Tobacco for Cancer

Source: Dr.Bicuspid.com February 14, 2012 -- Baseball Hall of Fame outfielder Tony Gwynn underwent surgery today in San Diego to remove a cancerous lesion in his mouth, according to an article on ESPN.com. This is the second time in two years that Gwynn has developed a malignant growth in his right cheek. He blames smokeless tobacco for the cancer; he dipped during his entire 20-year career with the San Diego Padres and for 10 years after that as well. Since the 2010 operation, however, Gwynn has not used smokeless tobacco, instead opting for a doctor-approved synthetic dip that he said "tasted awful." But last month, the cancer returned, according to ESPN. Doctors do not believe the cancer has spread outside of Gwynn's salivary gland, Gwynn's wife told ESPN. During the operation, doctors will conduct further biopsies of Gywnn's parotid gland, she said. Gwynn is currently the baseball coach at San Diego State. This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

2012-02-15T17:22:02-07:00February, 2012|Oral Cancer News|

Cigarette ads, packages must include oral cancer warnings, says FDA

Source: http://www.healthcanal.com/ Author: Craig Palmer, ADA News staff The Food and Drug Administration will require use of a “cancerous lesion on lip” image in cigarette advertising and packaging for its potential to motivate positive behavioral change, influence youth and young adults in particular and inform the public that cigarettes cause oral cancer. Flexing its regulatory muscle on the second anniversary of the Family Smoking Prevention and Tobacco Control Act, which was signed into law June 22, 2009, the FDA unveiled nine graphic health warnings to be placed on all cigarette packs, cartons and ads no later than Sept. 22, 2012. “The nine new health warning statements and the accompanying graphic images selected by FDA convey information that is factual and uncontroversial,” the agency said in the regulatory notice. The FDA simultaneously announced a public inquiry and request for comments on the public health impact of modified risk tobacco products sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. The FDA scheduled a public forum Aug. 25-26 to obtain information on “the scientific issues associated with assessment and ongoing review of MRTPs.” These include smokeless and other products promoted as alternatives to cigarette smoking. The Association supported the 2009 tobacco control law, and has advised the FDA on using the law to shape public tobacco policy. “Dentists are the first line of defense in the war against oral cancer and many other tobacco-related diseases,” the Association told the FDA in [...]

Go to Top